635,939 Concentrix Corporation $CNXC Shares Sold by Copeland Capital Management LLC

Key Points

• Copeland Capital Management sharply reduced its Concentrix position by selling 635,939 shares, cutting its holdings by 99.4% to 4,112 shares worth approximately $103,000. Institutional investors and hedge funds collectively own 90.34% of the stock.
• Concentrix beat quarterly EPS expectations, reporting $2.92 versus the $2.71 consensus, but revenue declined 1.2% year over year to $2.45 billion and the company posted a negative net margin of 23.99%.
• Shares opened at $26.66, while analysts maintain a consensus “Hold” rating and an average price target of $33.50. The company also raised its quarterly dividend to $0.37, implying a 5.6% annualized yield.

Copeland Capital Management LLC reduced its holdings in Concentrix Corporation (NASDAQ:CNXC - Free Report) by 99.4% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,112 shares of the company's stock after selling 635,939 shares during the quarter. Copeland Capital Management LLC's holdings in Concentrix were worth $103,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. GAMMA Investing LLC grew its stake in shares of Concentrix by 9.8% during the 3rd quarter. GAMMA Investing LLC now owns 4,556 shares of the company's stock worth $114,000 after purchasing an additional 405 shares during the period. Handelsbanken Fonder AB lifted its position in shares of Concentrix by 5.7% during the 2nd quarter. Handelsbanken Fonder AB now owns 11,200 shares of the company's stock valued at $251,000 after acquiring an additional 600 shares during the period. Northwestern Mutual Wealth Management Co. acquired a new stake in shares of Concentrix during the 2nd quarter valued at approximately $25,000. Nykredit A S purchased a new stake in shares of Concentrix during the 2nd quarter worth approximately $29,000. Finally, Webster Bank N. A. purchased a new stake in shares of Concentrix during the 1st quarter worth approximately $41,000. 90.34% of the stock is owned by institutional investors and hedge funds.

Concentrix Stock Performance

Shares of CNXC stock opened at $26.66 on Thursday. Concentrix Corporation has a one year low of $19.12 and a one year high of $48.08. The company has a debt-to-equity ratio of 2.22, a quick ratio of 1.23 and a current ratio of 1.23. The company has a 50 day moving average price of $27.32 and a 200 day moving average price of $26.19. The firm has a market capitalization of $1.63 billion, a price-to-earnings ratio of -0.69, a price-to-earnings-growth ratio of 0.51 and a beta of 0.52.

Concentrix (NASDAQ:CNXC - Get Free Report) last announced its quarterly earnings data on Tuesday, September 29th. The company reported $2.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.71 by $0.21. Concentrix had a negative net margin of 23.99% and a positive return on equity of 25.00%. The company had revenue of $2.45 billion during the quarter, compared to analysts' expectations of $2.48 billion. During the same period in the previous year, the company earned $2.78 EPS. The business's quarterly revenue was down 1.2% compared to the same quarter last year. Concentrix has set its FY 2026 guidance at 10.970-11.090 EPS and its Q4 2026 guidance at 2.860-2.980 EPS. Sell-side analysts anticipate that Concentrix Corporation will post 9.77 EPS for the current year.

Concentrix Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, November 3rd. Stockholders of record on Friday, October 23rd will be issued a $0.37 dividend. This is a positive change from Concentrix's previous quarterly dividend of $0.36. The ex-dividend date is Friday, October 23rd. This represents a $1.48 dividend on an annualized basis and a dividend yield of 5.6%. Concentrix's dividend payout ratio (DPR) is -3.70%.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on the stock. Robert W. Baird dropped their price objective on shares of Concentrix from $40.00 to $30.00 and set an "outperform" rating for the company in a research note on Tuesday, June 30th. Zacks Research upgraded Concentrix from a "strong sell" rating to a "hold" rating in a report on Monday, August 31st. Bank of America reiterated a "neutral" rating and issued a $29.00 price target on shares of Concentrix in a report on Thursday, October 1st. Barrington Research reduced their price target on Concentrix from $38.00 to $30.00 and set an "outperform" rating on the stock in a research note on Tuesday, June 30th. Finally, Weiss Ratings restated a "sell (d)" rating on shares of Concentrix in a report on Friday, July 24th. Three research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $33.50.

About Concentrix

Concentrix Corporation NASDAQ: CNXC is a global technology and services company that helps businesses improve customer engagement, operational performance and digital experiences. The company provides customer experience management, business process outsourcing, technology services and consulting to organizations across industries including technology, retail, healthcare, financial services, communications and travel.

Its offerings include customer care and technical support, sales and revenue generation, fraud prevention, analytics, artificial intelligence, automation, digital transformation and back-office services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.